Helmerich & Payne (NYSE:HP) received mixed analyst ratings over the past three months, with a shift towards a more bearish sentiment in the last 30 days. The average 12-month price target for HP is now $45.5, down from $48.25, with individual analyst actions including both downgrades and a single upgrade. The company has a strong market presence, reflected in its market capitalization, and has shown positive revenue growth, exceptional net margin, ROE, and ROA, along with prudent debt management. Analysts' ratings and price targets provide investors with insights into the company's expected performance.